证券记录 · 已归档季度
BBIO
BridgeBio Pharma, Inc. · Healthcare · Biotechnology
18被追踪持有人
-1Δ持有人
70.97M持有股份
$3.06B报告持仓市值
+1新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 -5.3% ·
股份流向 -3.1% ·
净新建仓位 -5.6%
— 公式
广泛派发 — 持股数量下降且持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 134 | +3 | 120.77M | $8.70B | +10 | −6 |
| Q1 2026 | 133 | +3 | 129.51M | $9.40B | +8 | −6 |
| Q4 2025 | 129 | +2 | 135.35M | $9.88B | +4 | −1 |
| Q3 2025 | 19 | -1 | 71.67M | $3.72B | — | −2 |
| Q2 2025 | 18 | -1 | 70.97M | $3.06B | +1 | −2 |
| Q1 2025 | 16 | +3 | 40.50M | $1.40B | +3 | — |
| Q4 2024 | 13 | 0 | 40.68M | $1.12B | +1 | −1 |
| Q3 2024 | 12 | -1 | 35.94M | $914.95M | — | −1 |
| Q2 2024 | 13 | — | 36.42M | $922.50M | — | — |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Viking Global Investors ✦ | 18.56M | -15.9% | $801.22M | 2.3% | ▼ Trim | 5 | SEC ↗ |
| 2 | The Vanguard Group ✦ (被动) | 16.48M | — | $711.82M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | The Vanguard Group ✦ (被动) | 16.48M | — | $711.82M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | The Vanguard Group ✦ (被动) | 16.48M | — | $711.82M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | The Vanguard Group ✦ (被动) | 16.48M | — | $711.82M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | The Vanguard Group ✦ (被动) | 16.48M | — | $711.82M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (被动) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (被动) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (被动) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (被动) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (被动) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (被动) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (被动) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (被动) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (被动) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (被动) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | BlackRock ✦ (被动) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | BlackRock ✦ (被动) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | BlackRock ✦ (被动) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | BlackRock ✦ (被动) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | BlackRock ✦ (被动) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | BlackRock ✦ (被动) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | BlackRock ✦ (被动) | 14.26M | — | $615.72M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | State Street Global Advisors ✦ (被动) | 5.90M | +2.6% | $254.62M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 28 | State Street Global Advisors ✦ (被动) | 5.90M | +2.6% | $254.62M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 29 | Geode Capital Management ✦ (被动) | 3.68M | +5.1% | $158.99M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | Geode Capital Management ✦ (被动) | 3.68M | +5.1% | $158.99M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | Two Sigma Investments ✦ | 2.34M | +177.4% | $101.00M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 32 | D. E. Shaw & Co. ✦ | 2.08M | +2403.0% | $89.87M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 33 | D. E. Shaw & Co. ✦ | 2.08M | +2403.0% | $89.87M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 34 | Fidelity (FMR) ✦ | 2.03M | — | $87.54M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Fidelity (FMR) ✦ | 2.03M | — | $87.54M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Fidelity (FMR) ✦ | 2.03M | — | $87.54M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Fidelity (FMR) ✦ | 2.03M | — | $87.54M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | Norges Bank ✦ (被动) | 1.96M | +57.2% | $84.49M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 39 | T. Rowe Price ✦ | 961.22K | -17.5% | $41.51M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 40 | T. Rowe Price ✦ | 961.22K | -17.5% | $41.51M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 41 | Millennium Management ✦ | 620.46K | +158.6% | $26.79M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 42 | Millennium Management ✦ | 620.46K | +158.6% | $26.79M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 43 | PRIMECAP Management ✦ | 588.71K | -35.5% | $25.42M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 44 | Marshall Wace ✦ | 422.71K | +0.2% | $18.25M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 45 | Marshall Wace ✦ | 422.71K | +0.2% | $18.25M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 46 | Citadel Advisors ✦ | 332.32K | -88.7% | $14.35M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 47 | Citadel Advisors ✦ | 332.32K | -88.7% | $14.35M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 48 | Citadel Advisors ✦ | 332.32K | -88.7% | $14.35M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 49 | Adage Capital Partners ✦ | 301.36K | -41.7% | $13.01M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 50 | Renaissance Technologies ✦ | 245.95K | 新增 | $10.62M | 0.0% | New | 1 | SEC ↗ |
| 51 | AQR Capital Management ✦ | 157.81K | +17.5% | $6.81M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 52 | AQR Capital Management ✦ | 157.81K | +17.5% | $6.81M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 53 | AQR Capital Management ✦ | 157.81K | +17.5% | $6.81M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 54 | AQR Capital Management ✦ | 157.81K | +17.5% | $6.81M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 55 | AQR Capital Management ✦ | 157.81K | +17.5% | $6.81M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 56 | Wellington Management ✦ | 56.67K | -5.6% | $2.45M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 57 | Wellington Management ✦ | 56.67K | -5.6% | $2.45M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 58 | Wellington Management ✦ | 56.67K | -5.6% | $2.45M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 59 | Wellington Management ✦ | 56.67K | -5.6% | $2.45M | 0.0% | ▼ Trim | 5 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Renaissance Technologies | $10.62M | 0.0% |
已清仓
| Duquesne Family Office | $15.14M | 曾为 0.5% |
| Point72 Asset Management | $6.87M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1 持有人, 15.30K 股份, $1,136 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 19
Kumar Neil
Officer, Director · 8.10K 股 · $679,256
Aug 19
Kumar Neil
Officer, Director · 1.80K 股 · $152,436
Aug 19
Kumar Neil
Officer, Director · 100 股 · $8,565
Aug 18
Kumar Neil
Officer, Director · 17.28K 股 · $1.42M
Aug 18
Kumar Neil
Officer, Director · 1.90K 股 · $154,184
Aug 18
Kumar Neil
Officer, Director · 14.60K 股 · $1.21M
Aug 18
Kumar Neil
Officer, Director · 1.20K 股 · $100,444
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 17
SC 13D/A — KKR Genetic Disorder L.P.
4.2% 占股份类别 · 查看 SEC 原始申报文件 ↗
Aug 03
SC 13G/A — FARALLON CAPITAL MANAGEMENT, L.L.C.
Jul 27
SC 13G/A — BlackRock, Inc.
Jul 10
SC 13D/A — VIKING GLOBAL INVESTORS LP
5.0% 占股份类别 · 查看 SEC 原始申报文件 ↗
May 29
SC 13G — Farallon Capital Partners, L.P.
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据